Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.4069
-0.0467 (-10.30%)
Nov 16, 2026, 4:00 PM EST - Market closed

Kairos Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.39-5.45-2.6-1.81-1.05-2.15
Depreciation & Amortization
0.10.160.160.160.160.1
Other Amortization
--0.150.060.410.14
Stock-Based Compensation
1.040.480.22--0.3
Other Operating Activities
1.052.170.10.91--
Change in Accounts Payable
0.09-0.790.40.770.131.19
Change in Other Net Operating Assets
-0-0.01-2.39-0.01--
Operating Cash Flow
-4.11-3.44-3.960.08-0.35-0.41
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Acquisitions
------0.11
Investing Cash Flow
------0.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.14---
Long-Term Debt Issued
-3.6--0.930.35
Total Debt Issued
-3.60.14-0.930.35
Short-Term Debt Repaid
---0.14--0.04-0.02
Total Debt Repaid
---0.14--0.04-0.02
Net Debt Issued (Repaid)
-3.6--0.890.33
Issuance of Common Stock
--5.52--0.25
Other Financing Activities
1.663.06-0.39-0.43-0.17-
Financing Cash Flow
1.666.665.13-0.430.720.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-2.453.221.18-0.340.360.06

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-2.55-1.63-5.350.760.010.47
Unlevered Free Cash Flow
-2.55-1.63-5.380.77-0.120.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0---
Change in Working Capital
0.09-0.81-1.980.760.131.19
SEC Filings: 10-K · 10-Q